BALPHARMA / NSE / Biotechnology & Drugs

Bal Pharma

INR 86.52.38 (0.60%) 1D

Last updated: 2026-06-15T13:33:16.326981+00:00

Price Chart

1Y Price Trend

Open107.2

High111.18

Low60

Close86.19

Volume70,095

Change-21.01

Change %-19.60%

Key Information

Ticker SymbolBALPHARMA

Current Price86.5

52-Week High111.18

52-Week Low60

Market Cap134.92

Beta1.01

Volume70,095

ISININE083D01012

Day High89.99

Day Low84.35

Open85.78

Recommendations

Target High112.97

Target Low59.69

Target Mean0

Target Median0

Risk Metrics

Overall RiskBalanced risk

Board Risk45

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

HEXAGON NUTRITION LTD. Stock/Share price , NSE/BSE Forecast News and Live Quotes - Equitymaster4 days ago

Market news

HEXAGON NUTRITION LTD. Stock/Share price , NSE/BSE Forecast News and Live Quotes Equitymaster

Bal Pharma Ltd Downgraded to Sell Amidst Flat Financials and Weak Fundamentals - Markets Mojo8 days ago

Market news

Bal Pharma Ltd Downgraded to Sell Amidst Flat Financials and Weak Fundamentals Markets Mojo

Golden Cross Forms in Bal Pharma Ltd — On a Day the Stock Fell 2.41%. What the Mixed Signals Mean - Markets Mojo8 days ago

Market news

Golden Cross Forms in Bal Pharma Ltd — On a Day the Stock Fell 2.41%. What the Mixed Signals Mean Markets Mojo

Bal Pharma Ltd Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends - Markets Mojo13 days ago

Market news

Bal Pharma Ltd Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends Markets Mojo

Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Market Volatility - Markets Mojo16 days ago

Market news

Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Market Volatility Markets Mojo

Bal Pharma Q4 FY26: Profitability Surge Masks Revenue Decline Concerns - Markets Mojo19 days ago

Market news

Bal Pharma Q4 FY26: Profitability Surge Masks Revenue Decline Concerns Markets Mojo

Bal Pharma FY26 net profit falls 13.4%, announces dividend - scanx.trade19 days ago

Market news

Bal Pharma FY26 net profit falls 13.4%, announces dividend scanx.trade

Nahar Spinning Mills Returns To Profit In Q4 As Revenue Climbs 30% Sequentially - Free Press Journal19 days ago

Market news

Nahar Spinning Mills Returns To Profit In Q4 As Revenue Climbs 30% Sequentially Free Press Journal